AU2001227768A1 - Improved synthesis of sulfurized oligonucleotides - Google Patents
Improved synthesis of sulfurized oligonucleotidesInfo
- Publication number
- AU2001227768A1 AU2001227768A1 AU2001227768A AU2776801A AU2001227768A1 AU 2001227768 A1 AU2001227768 A1 AU 2001227768A1 AU 2001227768 A AU2001227768 A AU 2001227768A AU 2776801 A AU2776801 A AU 2776801A AU 2001227768 A1 AU2001227768 A1 AU 2001227768A1
- Authority
- AU
- Australia
- Prior art keywords
- improved synthesis
- sulfurized oligonucleotides
- sulfurized
- oligonucleotides
- synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108091034117 Oligonucleotide Proteins 0.000 title 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09481486 | 2000-01-11 | ||
| US09/481,486 US6242591B1 (en) | 1997-10-15 | 2000-01-11 | Synthesis of sulfurized 2'-substituted oligonucleotides |
| PCT/US2001/000715 WO2001051502A1 (fr) | 2000-01-11 | 2001-01-10 | Synthese amelioree d'oligonucleotides soufres |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001227768A1 true AU2001227768A1 (en) | 2001-07-24 |
Family
ID=23912113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001227768A Abandoned AU2001227768A1 (en) | 2000-01-11 | 2001-01-10 | Improved synthesis of sulfurized oligonucleotides |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US6242591B1 (fr) |
| EP (1) | EP1246833A4 (fr) |
| JP (1) | JP2004500371A (fr) |
| KR (1) | KR20030032911A (fr) |
| AU (1) | AU2001227768A1 (fr) |
| CA (1) | CA2395765A1 (fr) |
| WO (1) | WO2001051502A1 (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6242591B1 (en) * | 1997-10-15 | 2001-06-05 | Isis Pharmaceuticals, Inc. | Synthesis of sulfurized 2'-substituted oligonucleotides |
| US20030087256A1 (en) * | 2001-04-06 | 2003-05-08 | Micrologix Biotech Inc. | Thiophosphate nucleic acid-based compounds |
| US7169916B2 (en) * | 2002-04-01 | 2007-01-30 | Isis Pharmaceuticals, Inc. | Chloral-free DCA in oligonucleotide synthesis |
| US7002006B2 (en) * | 2003-02-12 | 2006-02-21 | Isis Pharmaceuticals, Inc. | Protection of nucleosides |
| US20040198640A1 (en) * | 2003-04-02 | 2004-10-07 | Dharmacon, Inc. | Stabilized polynucleotides for use in RNA interference |
| US7276599B2 (en) * | 2003-06-02 | 2007-10-02 | Isis Pharmaceuticals, Inc. | Oligonucleotide synthesis with alternative solvents |
| CA2538252C (fr) * | 2003-09-18 | 2014-02-25 | Isis Pharmaceuticals, Inc. | 4'-thionucleosides et composes d'oligomeres |
| ES2535033T3 (es) | 2003-11-13 | 2015-05-04 | Isis Pharmaceuticals, Inc. | Derivados de 5,6 dihidroxi isoindol como conectores para la síntesis de oligómeros en fase sólida |
| KR101147147B1 (ko) * | 2004-04-01 | 2012-05-25 | 머크 샤프 앤드 돔 코포레이션 | Rna 간섭의 오프 타겟 효과 감소를 위한 변형된폴리뉴클레오타이드 |
| WO2005097817A2 (fr) | 2004-04-05 | 2005-10-20 | Alnylam Pharmaceuticals, Inc. | Procedes et reactifs pour la synthese et la purification d'oligonucleotides |
| WO2006023880A2 (fr) * | 2004-08-23 | 2006-03-02 | Isis Pharmaceuticals, Inc. | Composes et procedes permettant de caracteriser les oligonucleotides |
| US7923207B2 (en) | 2004-11-22 | 2011-04-12 | Dharmacon, Inc. | Apparatus and system having dry gene silencing pools |
| US7935811B2 (en) * | 2004-11-22 | 2011-05-03 | Dharmacon, Inc. | Apparatus and system having dry gene silencing compositions |
| US7923206B2 (en) * | 2004-11-22 | 2011-04-12 | Dharmacon, Inc. | Method of determining a cellular response to a biological agent |
| JP5352462B2 (ja) | 2006-09-22 | 2013-11-27 | ダーマコン, インコーポレイテッド | 二本鎖オリゴヌクレオチド複合体、rna干渉による遺伝子サイレンシング方法、および医薬品組成物 |
| US8188060B2 (en) | 2008-02-11 | 2012-05-29 | Dharmacon, Inc. | Duplex oligonucleotides with enhanced functionality in gene regulation |
| US7723528B2 (en) * | 2008-06-05 | 2010-05-25 | Am Chemicals Llc | Sulfur transfer reagents for oligonucleotide synthesis |
| EP2937358B1 (fr) * | 2008-06-23 | 2018-09-19 | Antisense Therapeutics Ltd | Procédés pour traiter la sclérose en plaques au moyen d'oligonucléotides antisens |
| US8552175B2 (en) | 2009-04-23 | 2013-10-08 | A.M. Chemicals, Inc. | Sulfur transfer reagents for oligonucleotide synthesis |
| US8309710B2 (en) | 2009-06-29 | 2012-11-13 | Agilent Technologies, Inc. | Use of N-alkyl imidazole for sulfurization of oligonucleotides with an acetyl disulfide |
| US8642755B2 (en) * | 2009-06-30 | 2014-02-04 | Agilent Technologies, Inc. | Use of thioacetic acid derivatives in the sulfurization of oligonucleotides with phenylacetyl disulfide |
| CN103068982B (zh) * | 2010-07-14 | 2017-06-09 | 库尔纳公司 | 通过抑制盘状大同系物(dlg)的天然反义转录物而治疗dlg相关疾病 |
| WO2012059510A1 (fr) | 2010-11-02 | 2012-05-10 | Girindus America, Inc. | Maîtrise de la contrepression au cours d'une synthèse en phase solide sur supports polymères |
| CA3163857A1 (fr) | 2020-01-15 | 2021-07-22 | Weimin Wang | Acides nucleiques phosphonate de 4'-o-methylene et analogues de ceux-ci |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3923763A (en) * | 1972-09-15 | 1975-12-02 | Petro Tex Chem Corp | Novel sulfur compound modifiers for chloroprene polymerization |
| JPS5442617B2 (fr) | 1974-12-28 | 1979-12-15 | ||
| US4959463A (en) * | 1985-10-15 | 1990-09-25 | Genentech, Inc. | Intermediates |
| NL8902521A (nl) | 1989-10-11 | 1991-05-01 | Rijksuniversiteit | Werkwijze voor het bereiden van fosforothioaatesters. |
| US5151510A (en) * | 1990-04-20 | 1992-09-29 | Applied Biosystems, Inc. | Method of synethesizing sulfurized oligonucleotide analogs |
| GB9127243D0 (en) | 1991-12-23 | 1992-02-19 | King S College London | Synthesis of phosphorothioate analogues of oligonucleotides |
| US5574146A (en) | 1994-08-30 | 1996-11-12 | Beckman Instruments, Inc. | Oligonucleotide synthesis with substituted aryl carboxylic acids as activators |
| US6001555A (en) * | 1994-09-23 | 1999-12-14 | The United States Of America As Represented By The Department Of Health And Human Services | Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein |
| US5902881A (en) * | 1997-03-03 | 1999-05-11 | Isis Pharmaceuticals, Inc. | Reagent useful for synthesizing sulfurized oligonucleotide analogs |
| US6114519A (en) * | 1997-10-15 | 2000-09-05 | Isis Pharmaceuticals, Inc. | Synthesis of sulfurized oligonucleotides |
| US6242591B1 (en) * | 1997-10-15 | 2001-06-05 | Isis Pharmaceuticals, Inc. | Synthesis of sulfurized 2'-substituted oligonucleotides |
| US6114518A (en) * | 1999-09-30 | 2000-09-05 | Becton, Dickinson And Company | Synthesis and use of labelled phosphoramidite compositions |
-
2000
- 2000-01-11 US US09/481,486 patent/US6242591B1/en not_active Expired - Lifetime
-
2001
- 2001-01-10 AU AU2001227768A patent/AU2001227768A1/en not_active Abandoned
- 2001-01-10 US US10/181,200 patent/US7227015B2/en not_active Expired - Fee Related
- 2001-01-10 KR KR1020027008933A patent/KR20030032911A/ko not_active Withdrawn
- 2001-01-10 JP JP2001551086A patent/JP2004500371A/ja not_active Withdrawn
- 2001-01-10 EP EP01901916A patent/EP1246833A4/fr not_active Withdrawn
- 2001-01-10 CA CA002395765A patent/CA2395765A1/fr not_active Abandoned
- 2001-01-10 WO PCT/US2001/000715 patent/WO2001051502A1/fr not_active Ceased
-
2004
- 2004-05-17 US US10/847,502 patent/US7378516B2/en not_active Expired - Fee Related
-
2008
- 2008-04-21 US US12/106,889 patent/US7723511B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001051502A1 (fr) | 2001-07-19 |
| EP1246833A4 (fr) | 2003-04-09 |
| EP1246833A1 (fr) | 2002-10-09 |
| US20050165226A1 (en) | 2005-07-28 |
| JP2004500371A (ja) | 2004-01-08 |
| US20080293929A1 (en) | 2008-11-27 |
| CA2395765A1 (fr) | 2001-07-19 |
| US7227015B2 (en) | 2007-06-05 |
| US7723511B2 (en) | 2010-05-25 |
| US6242591B1 (en) | 2001-06-05 |
| US7378516B2 (en) | 2008-05-27 |
| KR20030032911A (ko) | 2003-04-26 |
| US20030212267A1 (en) | 2003-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001227768A1 (en) | Improved synthesis of sulfurized oligonucleotides | |
| AU2792499A (en) | Improved methods for synthesis of oligonucleotides | |
| AU3771100A (en) | Synthesis of epothilones | |
| AU2002332090A1 (en) | Efficient synthesis of protein-oligonucleotide conjugates | |
| AU2001284697A1 (en) | Method of synthesizing diketopiperazines | |
| AU2002211542A1 (en) | Combinatorial synthesis system | |
| AU2001272904A1 (en) | Synthesis of 17f labeled fluoroalkanes | |
| AU2001237992A1 (en) | Purification of oligonucleotides | |
| GB0100628D0 (en) | Synthesis of tetramethylammonium hydroxide | |
| AU2001241539A1 (en) | Synthesis of resveratrol | |
| AU2001269685A1 (en) | Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis | |
| MXPA03000914A (es) | Sintesis de (r)-3-(4 -bromobencil) -1-(3, 5-diclorofenil) -5-yodo-3 -metil-1-h -imidazo[1, 2-a]imidazol -2-ona. | |
| AU2002316593A1 (en) | Solid phase synthesis of arylretinamides | |
| AU2001253143A1 (en) | Synthesis of cyclohexene dimethanol compounds | |
| AU2001277728A1 (en) | Biphenylcarboxamidoisoindoline compounds, processes for the preparation of the same and intermediates for the synthesis thereof | |
| AU2402600A (en) | Pentafulvene synthesis | |
| AUPR197000A0 (en) | Synthesis of small particles | |
| GB0014876D0 (en) | Chemical synthesis | |
| GB0004699D0 (en) | Chemical synthesis | |
| AU2002236882A1 (en) | Improved methods for synthesis of oligonucleotides | |
| AU3739300A (en) | Synthesis of vapol ligands | |
| GB0002333D0 (en) | Compound synthesis | |
| AU2001287422A1 (en) | Synthesis of complex carbohydrates | |
| AU2001259381A1 (en) | Synthesis of diphosphinoarenes | |
| AU2001249683A1 (en) | Synthesis of thiazolium compounds |